Anixa Biosciences (ANIX) FCF Margin Growth (1y) (2011 - 2019)
Anixa Biosciences (ANIX) FCF Margin Growth (1y) (2011 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 811.00 |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2019 | -47,366.00 |
| Jul 31, 2018 | 1,763.00 |
| Jul 31, 2017 | 47,232.00 |
| Jul 31, 2016 | -7,239.00 |
| Jul 31, 2015 | -71,743.00 |
| Oct 31, 2012 | -27.48 Mn |
| Jul 31, 2012 | -54,759.00 |
| Apr 30, 2012 | 47,780.00 |
| Jan 31, 2012 | 348,538.00 |
| Oct 31, 2011 | 745.00 |